Table 2.
Clinical characteristic | HAART-naïve | HAART-experienced | Total |
---|---|---|---|
| |||
n (%) | n (%) | N (%) | |
WHO staging | |||
I | 64 (57.2) | 47 (41.9) | 111 (49.6) |
II | 36 (32.1) | 32 (28.6) | 68 (30.3) |
III | 12 (10.7) | 30 (26.8) | 42 (18.8) |
IV | 0 | 3 (2.7) | 3 (1.3) |
Immune status | |||
Severe immunosuppression | 17 (15.2) | 23 (20.5) | 40 (17.9) |
Advanced immunosuppression | 12 (10.7) | 17 (15.2) | 29 (12.9) |
Mild immunosuppression | 40 (35.7) | 32 (28.6) | 72 (32.1) |
Normal immune status | 43 (38.4) | 40 (37.7) | 83 (37.1) |
Weight-for-age status | |||
Underweight | 30 (26.8) | 44 (39.3) | 74 (33) |
Normal | 82 (73.2) | 68 (60.7.) | 150 (67) |
Height-for-age status | |||
Stunted | 39 (34.8) | 31 (27.7) | 70 (31.3) |
Normal | 73 (65.2) | 81 (72.3) | 154 (68.7) |
OIs | |||
Yes | 15 (13.4) | 10 (9) | 25 (11.2) |
No | 97 (86.6) | 102 (91) | 212 (88.8) |
Gastroenteritis | |||
Yes | 6 (5.4) | 9 (8) | 15 (6.7) |
No | 106 (94.6) | 103 (92) | 209 (93.3) |
Pneumonia | |||
Yes | 14 (12.5) | 10 (9) | 24 (10.7) |
No | 98 (87.5) | 102 (91) | 200 (89.3) |
Oral thrush | |||
Yes | 9 (8) | 5 (4.5) | 14 (6.2) |
No | 103 (92) | 107 (95.5) | 210 (93.8) |
Skin rash | |||
Yes | 16 (14.3) | 14 (12.5) | 30 (13.4) |
No | 96 (85.7) | 98 (87.5) | 194 (86.4) |
Fever | |||
Yes | 19 (17) | 13 (11.6) | 32 (14.3) |
No | 93 (83) | 99 (88.4) | 192 (85.7) |
Presence of diarrhea | |||
Yes | 15 (13.4) | 8 (7.1) | 23 (10.3) |
No | 97 (86.6) | 104 (92.9) | 201 (89.7) |
Kind of diarrhea | |||
Acute | 8 (53.3) | 7 (87.5) | 15 (65.2) |
Chronic | 7 (46.7) | 1 (12.5) | 8 (34. 8) |
Abbreviations: ART, antiretroviral treatment; HAART, highly active antiretroviral therapy; HIV, human immunodeficiency virus; OIs, opportunistic infections; WHO, World Health Organization.